American Association for Cancer Research
From molecules to medicine, from proteomics to prevention, the journals of the AACR cover the full spectrum of cancer science and medicine. To submit your manuscript, please select the journal that aligns with your research and follow the instructions to …
Select an AACR Journal - American Association for Cancer Research
Cancer Prevention Research is devoted exclusively to cancer prevention. The Journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them.
American Association for Cancer Research
About the Journal. Cancer Research publishes impactful original studies, reviews, and opinion pieces of high significance to the broad cancer research community.Cancer Research seeks manuscripts that offer conceptual or technological advances leading to basic and translational insights into cancer biology.Read More About the Journal
American Association for Cancer Research
About the Journal. Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; …
Cancer Epidemiology, Biomarkers & Prevention | American …
About the Journal. Cancer Epidemiology, Biomarkers & Prevention publishes articles featuring population-based research on cancer etiology, prevention, surveillance, survivorship, and cancer health disparities—with a particular focus on articles with a transdisciplinary approach.Read More About the Journal
Volume 18 Issue 1 - American Association for Cancer Research
2025年1月1日 · Cancer Prevention Research | 18 | 1 | January 2025. NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author.
Volume 34 Issue 1 - American Association for Cancer Research
2025年1月1日 · Cancer Epidemiology, Biomarkers & Prevention | 34 | 1 | January 2025. NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific ...
Volume 85 Issue 1 - American Association for Cancer Research
Cancer Research | 85 | 1 | January 2025. NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author.
Information for Authors - American Association for Cancer Research
Select an AACR Journal. The ten AACR journals vary in scope and selectivity. If you are unsure which journal would be most appropriate for your manuscript, please review the journal descriptions on this page.Detailed metrics, including the Impact Factors, of the AACR journals can be found at AACR Journals Metrics.. Editorial Process
AACR Cancer Progress Report 2024 - American Association for …
2024年10月1日 · The annual American Association for Cancer Research (AACR) Cancer Progress Report is a cornerstone of AACR’s efforts to educate the public and the Congress about the latest advances against cancer and the importance of medical research, as well as to advocate for increased federal funding for the National Institutes of Health (NIH), National Cancer Institute (NCI), U.S. Food and Drug ...